Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4632531000168116 | burosumab 30 mg / 1 mL injection, 1 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4632541000168113 | burosumab 30 mg/mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| burosumab 30 mg/mL injection, vial | Is a | burosumab | true | Inferred relationship | Some | ||
| burosumab 30 mg/mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| burosumab 30 mg/mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| burosumab 30 mg/mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 24913877 | |
| burosumab 30 mg/mL injection, vial | has Australian BoSS | burosumab | true | Inferred relationship | Some | 1589391318 | |
| burosumab 30 mg/mL injection, vial | has intended active ingredient | burosumab | true | Inferred relationship | Some | 1589391318 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Crysvita 30 mg/mL injection, 1 mL vial | Is a | True | burosumab 30 mg/mL injection, vial | Inferred relationship | Some | |
| burosumab 30 mg/mL injection, 1 mL vial | has MPUU | True | burosumab 30 mg/mL injection, vial | Inferred relationship | Some | 2009080215 |
Reference Sets
Description inactivation indicator reference set
REPLACED BY association reference set
Medicinal product unit of use reference set
FHIR